37.87
-1.36 (-3.47%)
-1.36 (-3.47%)
Upgrade to Real-Time
Afterhours (Closed)
Low
3.59
High
80.67
Best deals to access real time data! |
|
CHART Trader
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Brooklyn ImmunoTherapeutics Inc | BTX | AMEX | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -1.36 | -3.47% | 37.87 | 19:59:57 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 41.26 | 37.11 | 44.85 | 38.45 | 39.23 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 50,031 | 5,689,433 | $ 40.54 | $ 230,670,005 | 10,039,824 | 3.59 - 80.67 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 20:00:00 | 11,215 | $ 38.45 | USD |
Brooklyn ImmunoTherapeut... Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 1.57B | 41.51M | 1.72M | $ - | $ - | -1.50 | -2.00 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | -16.04k | 0.40% |
Brooklyn ImmunoTherapeut... News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BTX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 31.17 | 80.67 | 29.41 | 55.10 | 26,635,033 | 6.70 | 21.5% |
| 1 Month | 4.86 | 80.67 | 4.86 | 42.37 | 14,410,955 | 33.01 | 679.22% |
| 3 Months | 4.90 | 80.67 | 3.59 | 36.86 | 11,882,335 | 32.97 | 672.86% |
| 6 Months | 4.90 | 80.67 | 3.59 | 36.86 | 11,882,335 | 32.97 | 672.86% |
| 1 Year | 4.90 | 80.67 | 3.59 | 36.86 | 11,882,335 | 32.97 | 672.86% |
| 3 Years | 2.23 | 80.67 | 0.66 | 24.43 | 1,586,603 | 35.64 | 1,598.21% |
| 5 Years | 2.75 | 80.67 | 0.66 | 19.31 | 852,952 | 35.12 | 1,277.09% |
Brooklyn ImmunoTherapeut... Description
| Brooklyn ImmunoTherapeutics Inc is a clinical stage biopharmaceutical company. It is developing IRX-2, a novel hd-IL-2 -based therapy, to treat patients with cancer. IRX-2 delivers hd-IL-2 and other key cytokines to potentially restore immune function in the tumor microenvironment, enabling the immune system to attack cancer cells. |
